Connect with us

Business

Core One Labs (OTCMKTS:CLABF) To Expand To Europe After Filing Additional Trademark Application

Published

on

Core One Labs Inc. (OTCMKTS:CLABF) has announced the filing of a Trademark Application with WIPO Madrid in addition to the company’s CannaStrips filings. The Applications intends to trademark “CBDSTRIPS in Germany, Spain, as well as the UK.

Core One Labs plotting expansion to Europe

This filing of additional Trademarks by the company intends to protect Core One Labs’ future product brands across Europe. This is part of the company’s expected expansion into the European marketplace. The countries the company identified in the application appeared to be the most viable countries where they will distribute the COOL products.

Currently, the company can’t distribute its products outside the state of California. But the protection of the company’s technology and brands across the world indicates that there is a possibility of expanding to different places. The company can achieve this through a licensing agreement or joint ventures. Core One Labs has future global expectations for its COOL products as well as for the CannaStrip brand.

Brad Eckenweiler, the CEO of Core One Labs, indicated that the company was establishing foundations globally that will benefit the company in the future. Brad added that it is important to build for the future and identify opportunities as well as innovations that support Core One Labs’ mission and business model.

Core One Labs produces CannaStrips using the latest tech

The company uses the latest technology in its production and packaging facility in California. It produces infused strips that offer a better delivery option compared to other options. Similarly, the strips have premium bioavailability of cannabis ingredients, with some even having co-active constituents such as vitamins, nutraceuticals, and peptides.

CannaStriups are oral strips that offer effective buccal mucosa delivery by disrupting the barrier formed by saliva coating the mucosa membrane. This allows the CBD ingredients encapsulated and nanoparticulated in the strips to pass through multiple mucosal membranes into the bloodstream. Once in the system, encapsulation prevents the liver from filtering the material out of the bloodstream as foreign material. This, therefore, increases bioavailability, thus increasing the effective time of a single dose.

*Past performance is not a predictor of future results. All investing involves risk of loss and individual investments may vary. The examples provided may not be representative of typical results. Your capital is at risk when you invest – you can lose some or all of your money. Never risk more than you can afford to lose.By submitting your information you agree to the terms of our Privacy Policy • Cancel Newsletter Any Time.This is a FREE service from Finacials Trend. Signing up for our FREE daily e-letter also entitles you to receive this report. We will NOT share your email address with anyone.

FEATURED STORIES

Business23 hours ago

Planet 13 Holdings Inc. (OTCMKTS:PLNHF) Signs Purchase Agreement To Acquire 45,000 Sq. ft. Facility In Nevada

Post Views: 115 Planet 13 Holdings Inc. (OTCMKTS:PLNHF) announced the signing of an asset purchase agreement subject to which it...

Business2 days ago

Indus Holdings Inc. (OTCMKTS:INDXF) Terminates Its Pending $20 million Acquisition Agreement Of W Vapes Assets

Post Views: 146 Indus Holdings Inc. (OTCMKTS:INDXF) announced termination of its impending acquisition of W Vapes assets that was announced...

Business2 days ago

1933 Industries Inc. (OTCMKTS:TGIFF) Introduces Pre-roll Joints And Smokable Cannabis Flower In Nevada

Post Views: 134 1933 Industries Inc. (OTCMKTS:TGIFF) announced addition of pre-joint rolls and high-quality smokable flowers to its growing consumer...

Business3 days ago

Cannabis Pharmaceuticals Inc. (OTCMKTS:CNBX) Initiates Expansion Of Its Cannabinoid Diagnostic Platform Tests In Europe

Post Views: 63 Cannabis Pharmaceuticals Inc. (OTCMKTS:CNBX) commenced expansion in the European markets to offer cancer patients tailored cannabinoid treatment...

INDUSTRIAL HEMP3 days ago

Generex Biotechnology Corporation (OTCMKTS:GNBT) Submits Pre-IND For Ii-Key-SARS-CoV-2 Vaccine To The FDA

Post Views: 198 Generex Biotechnology Corporation (OTCMKTS:GNBT) submitted a Pre-IND update to the FDA outlining its proposed Phase I/II clinical...

Business6 days ago

cbdMD Inc. (NYSEAMERICAN:YCBD) Protecting Its CBD Technologies Through Patents and expands Partnership With Bellator MMA

Post Views: 310 cbdMD Inc. (NYSEAMERICAN:YCBD) announced an extension of the exclusive Official CBD marketing partnership with ViacomCBS’s wholly-owned subsidiary...